Cardiovascular InflammationCardiovascular Inflammation
Prevalência: hs-CRP >2 mg/L present in ~25% of US adults
Evidence-Ranked Ingredients
About
Chronic low-grade systemic inflammation measured by hs-CRP, now recognized as an independent cardiovascular risk factor. The CANTOS trial validated the inflammatory hypothesis of atherosclerosis by showing reducing inflammation (IL-1beta) without affecting lipids reduced cardiovascular events.
Common Symptoms
Risk Factors
- Obesity (visceral adiposity)
- Metabolic syndrome
- Periodontal disease
- Autoimmune conditions
- Smoking
- Sedentary lifestyle
- Poor diet
Frequently Asked Questions
What supplements may help with Cardiovascular Inflammation?
How is the evidence for Cardiovascular Inflammation supplements graded?
How many studies on Cardiovascular Inflammation supplements have been reviewed?
What are common symptoms of Cardiovascular Inflammation?
Related Conditions
Condições que partilham ingredientes estudados
Aviso Legal da FDA: Estas declarações não foram avaliadas pela Food and Drug Administration. Os produtos e informações neste site não se destinam a diagnosticar, tratar, curar ou prevenir qualquer doença. As notas de evidência apresentadas são baseadas em nossa análise de pesquisas revisadas por pares publicadas e não constituem aconselhamento médico. Sempre consulte seu profissional de saúde antes de iniciar qualquer regime de suplementação.